TSHA - Company ID 0001806310
As of 2026-09-07, Taysha Gene Therapies, Inc. (TSHA) has a market capitalization of $1.61 B, making it the #2306 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $1.61 B |
| 2026-09-06 | $1.61 B |
| 2026-09-05 | $1.61 B |
| 2026-09-04 | $1.61 B |
| 2026-09-03 | $1.60 B |
| 2026-09-02 | $1.62 B |
| 2026-09-01 | $1.64 B |
| 2026-08-31 | $1.64 B |
| 2026-08-30 | $1.66 B |
| 2026-08-29 | $1.66 B |
| 2026-08-28 | $1.66 B |
| 2026-08-27 | $1.71 B |
As of 2026-09-07, Taysha Gene Therapies, Inc. (TSHA) has a market capitalization of $1.61 B, making it the #2306 most valuable US-listed company.
Taysha Gene Therapies, Inc. is the #2306 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $1.73 B |
| 2026-08-25 | $1.78 B |
| 2026-08-24 | $1.74 B |
| 2026-08-23 | $1.75 B |
| 2026-08-22 | $1.75 B |
| 2026-08-21 | $1.75 B |
| 2026-08-20 | $1.74 B |
| 2026-08-19 | $1.85 B |
| 2026-08-18 | $1.78 B |
| 2026-08-17 | $1.77 B |
| 2026-08-16 | $1.71 B |
| 2026-08-15 | $1.71 B |
| 2026-08-14 | $1.71 B |
| 2026-08-13 | $1.72 B |
| 2026-08-12 | $1.84 B |
| 2026-08-11 | $1.88 B |
| 2026-08-10 | $1.83 B |
| 2026-08-09 | $1.89 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.